ZVRA EBITDA Growth
Zevra Therapeutics Inc · EBITDA Growth
ZVRA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported100.47%period ending
ZVRA TTM EBITDA YoY % (-305.96% → 100.47%)
Year-over-year change
High-resolution chart · PNG
ZVRA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 100.4692% | |
| 332.9348% | |
| 229.2003% | |
| 191.458% | |
| 163.2418% | |
| -37.6269% | |
| -79.8451% | |
| -95.3946% | |
| -90.2228% | |
| 16.4802% | |
| -3.1042% | |
| -7.2522% | |
| 1.0808% | |
| -25,567.4757% | |
| -422.9344% | |
| -314.6269% | |
| -282.6337% | |
| 101.7762% | |
| -47.464% | |
| -34.8589% | |
| -363.7312% | |
| 3.9742% | |
| 72.0803% | |
| 65.9203% | |
| 95.0784% | |
| 66.031% | |
| 61.0886% | |
| 66.2299% | |
| 28.7036% | |
| 22.1168% | |
| -37.5461% | |
| -55.1553% | |
| -27.3666% | |
| -5.5268% | |
| -18.5898% | |
| -16.6047% | |
| -42.5355% | |
| 6.8452% | |
| 39.6678% | |
| 39.0759% | |
| 42.8439% | |
| -115.9116% | |
| -170.6286% | |
| -305.9583% |